These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38742515)

  • 1. Features of The Dynamics of Profibrotic Markers and Regression of Left Ventricular Hypertrophy After Renal Denervation in Patients With Resistant Hypertension and Stenosing Atherosclerosis of the Coronary Arteries.
    Zyubanova IV; Falkovckaya AY; Manukyan MA; Solonskaya EI; Vtorushina AA; Khunkhinova SA; Gusakova AM; Pekarskiy SE; Mordovin VF
    Kardiologiia; 2024 Apr; 64(4):45-53. PubMed ID: 38742515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.
    Brandt MC; Mahfoud F; Reda S; Schirmer SH; Erdmann E; Böhm M; Hoppe UC
    J Am Coll Cardiol; 2012 Mar; 59(10):901-9. PubMed ID: 22381425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
    Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
    Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of multielectrode renal denervation on cardiac adaptations in resistant hypertensive patients with left ventricular hypertrophy.
    Tsioufis C; Papademetriou V; Dimitriadis K; Kasiakogias A; Kordalis A; Andrikou E; Milkas A; Liatakis I; Lau EO; Tousoulis D
    J Hum Hypertens; 2016 Nov; 30(11):714-719. PubMed ID: 26818805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction In Patients With Resistant Hypertension and Type 2 Diabetes Mellitus.
    Manukyan MA; Falkovskaya AY; Zyubanova IV; Lichikaki VA; Tsoi EI; Ryabova TR; Gusakova AM; Suslova TE; Mordovin VF
    Kardiologiia; 2022 Aug; 62(8):11-18. PubMed ID: 36066982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductions of left ventricular mass and atrial size following renal denervation: a meta-analysis.
    Lu D; Wang K; Liu Q; Wang S; Zhang Q; Shan Q
    Clin Res Cardiol; 2016 Aug; 105(8):648-656. PubMed ID: 26838292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of matrix metalloproteinases activity in acute myocardial infarction.
    Papadopoulos DP; Moyssakis I; Makris TK; Poulakou M; Stavroulakis G; Perrea D; Votteas VE
    Eur Cytokine Netw; 2005 Jun; 16(2):152-60. PubMed ID: 15941687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects.
    Saglam M; Karakaya O; Esen AM; Barutcu I; Dogan S; Karavelioglu Y; Karapinar H; Akgun T; Esen O; Ozdemir N; Turkmen S; Kaymaz C
    Tohoku J Exp Med; 2006 Feb; 208(2):117-22. PubMed ID: 16434834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential reduction of interstitial myocardial fibrosis with renal denervation.
    Doltra A; Messroghli D; Stawowy P; Hassel JH; Gebker R; Leppänen O; Gräfe M; Schneeweis C; Schnackenburg B; Fleck E; Kelle S
    J Am Heart Assoc; 2014 Dec; 3(6):e001353. PubMed ID: 25516438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).
    Bonnema DD; Webb CS; Pennington WR; Stroud RE; Leonardi AE; Clark LL; McClure CD; Finklea L; Spinale FG; Zile MR
    J Card Fail; 2007 Sep; 13(7):530-40. PubMed ID: 17826643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.
    Mahfoud F; Urban D; Teller D; Linz D; Stawowy P; Hassel JH; Fries P; Dreysse S; Wellnhofer E; Schneider G; Buecker A; Schneeweis C; Doltra A; Schlaich MP; Esler MD; Fleck E; Böhm M; Kelle S
    Eur Heart J; 2014 Sep; 35(33):2224-31b. PubMed ID: 24603307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy: an EnligHTN I substudy.
    Tsioufis C; Papademetriou V; Dimitriadis K; Tsiachris D; Thomopoulos C; Kasiakogias A; Kordalis A; Kefala A; Koutra E; Lau EO; Grassi G; Stefanadis C
    J Hypertens; 2015 Feb; 33(2):346-53. PubMed ID: 25380167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of benidipine hydrochloride on severe left ventricular hypertrophy and collagen metabolism in patients with essential hypertension.
    Hirono O; Fatema K; Nitobe J; Takeishi Y; Kaneko K; Shiga R; Kubota I
    J Cardiol; 2002 Apr; 39(4):195-204. PubMed ID: 11977767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension.
    Dörr O; Liebetrau C; Möllmann H; Mahfoud F; Ewen S; Gaede L; Troidl C; Hoffmann J; Busch N; Laux G; Wiebe J; Bauer T; Hamm C; Nef H
    Clin Res Cardiol; 2015 Feb; 104(2):175-84. PubMed ID: 25326158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte membranes beta-adrenoreactivity changes after renal denervation in patients with resistant hypertension, relationship with antihypertensive and cardioprotective intervention efficacy.
    Zyubanova IV; Falkovskaya AY; Mordovin VF; Manukyan MA; Pekarskij SE; Lichikaki VA; Shalishev IG; Rebrova TY; Muslimova EF; Afanasiev SA
    Kardiologiia; 2021 Aug; 61(8):32-39. PubMed ID: 34549691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
    Zhang ZL; Lin JH; Tao RQ
    Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.